It histone deacetylase inhibitor (HDACIs) and is disclosed containing its composition. The disease for the treatment of and the method for symptom wherein inhibit HDAC to provide benefit, and such as cancer, neurodegenerative disorders, neurological disease, traumatic brain injury, apoplexy, malaria, autoimmune disease, autism, inflammation is also disclosed for.